A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer
Clinical trial NCT04809142 · UNKNOWN
Trial details
- NCT number
- NCT04809142
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2022-03-18
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.